Could PerkinElmer Be The Next Danaher?


  • PerkinElmer, Inc. might have outperformed the S&P 500 over the last decade, but it didn’t perform as well as some of its peers.
  • PerkinElmer has many similarities to Danaher Corporation and could be a great buy here.
  • Both companies recently announced divestitures to focus on their core Life Sciences and Diagnostics businesses.
  • PerkinElmer could be an opportunity to outperform the market over the next decade as well.

Teenage student using the microscope in the laboratory

FG Trade

Can a restructuring lead to outperformance?

PerkinElmer, Inc. (NYSE:PKI) is an American Medical Devices company focused on life sciences and diagnostics. Over the last ten years, the company outperformed the S&P 500 by a wide margin but did not

Peer group comparison

Peer group comparison (Koyfin)

PKI at a glance

PKI at a glance (PKI Investor Presentation)

Danaher Overview

Danaher Overview (Danaher Investor presentation)

PKI capital deployment

PKI capital deployment (Koyfin)

Return on Capital comparison

Return on Capital comparison (Authors Model)

Valuation Comparison

Valuation Comparison (Koyfin)

Disclosure: I/we have a beneficial long position in the shares of DHR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: What do you think about PerkinElmer and Danaher? Let’s continue the discussion in the comments below. This is not financial advice.

Leave a Reply

Your email address will not be published. Required fields are marked *